Live Imaging Reveals a New Role for the Sigma-1 Receptor in Allowing Microglia to Leave Brain InjuryMar 10, 2015Neuroscience Letters 591 (2015)Christian Moritz, Francesco Berardi, Carmen Abate and Francesca PeriView Paper
Neuroscience Letters 591 (2015)Christian Moritz, Francesco Berardi, Carmen Abate and Francesca PeriView Paper
Anavex Life Sciences Announces Issuance of Blarcamesine (ANAVEX®2-73) Composition of Matter U.S. Patent Expanding its Intellectual Property Portfolio
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III Data in The Journal of Prevention of Alzheimer’s Disease
New Phase IIb/III Clinical Data Demonstrates Over Three Years of Continuous Treatment with Oral Blarcamesine to Significantly Benefit Early Alzheimer’s Disease Patients
